- Global Pharma News & Resources

CTI BioPharma to Present at the 8th Annual SVB Leerink Global Healthcare Conference Wednesday, Feb. 27

SEATTLE, Feb. 20, 2019 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will provide a corporate overview at the 8th Annual SVB Leerink Global Healthcare Conference at 11:30 a.m. EST at the Lotte New York Palace Hotel.

Presentation details:


8th Annual SVB Leerink Global Healthcare Conference


Wednesday, Feb. 27


11:30 a.m. EST

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at

About CTI BioPharma Corp.

CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The CTI BioPharma lead product candidate, pacritinib, is being developed for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington.  For additional information and to sign up for email alerts and get RSS feeds, please visit

CTI BioPharma Investor Contacts:

Argot Partners
Maeve Conneighton


View original content to download multimedia:

SOURCE CTI BioPharma Corp.

Editor Details

Last Updated: 20-Feb-2019